Upgrade to SI Premium - Free Trial

Alexion Pharma (ALXN) Tops Q3 EPS by 32c, Raises FY Guidance

October 23, 2019 6:35 AM
Alexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $2.79, $0.32 better than the analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles